The new Rutgers REACH hub will identify innovative health-related technologies by using the expertise of the National Cancer Institute-funded Rutgers Cancer Institute, RITMS, and the New Jersey Center for Biomaterials (NJCBM). These technologies will be evaluated for commercialization feasibility, especially as they relate to providing precision therapy to tackle an unmet need created by the heterogeneity of disease development and response to treatment. Addressing such needs can provide assets tailored to patients’ therapeutic responses that ultimately improve health. To learn more about the hub.
Home / News / From NJBIZ.com: Rutgers ROI Program to integrate strengths in biomedical sciences, expertise in research commercialization
Recent Posts
- NJACTS Community Engagement Core COVID-19 Resources
- Researchers Map Where Solar Energy Delivers the Biggest Climate Payoff.
- Internalizing Stress May Lead to Cognitive Decline in Older Chinese Americans.
- Major autism study uncovers biologically distinct subtypes, paving the way for precision diagnosis and care.
- 6 Subtle Signs of a Staph Infection You Need to Know, According to Doctors.
Categories
- Community (2,331)
- Covid (991)
- CTO Events (6)
- News (2,964)
- Pilots (21)